Artelo Biosciences
ARTL
ARTL
15 hedge funds and large institutions have $443K invested in Artelo Biosciences in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$21.6K | |
| 2 | +$12.5K | |
| 3 | +$10K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$6.07K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$5.73K |
Top Sellers
| 1 | -$82K | |
| 2 | -$12K | |
| 3 | -$8K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6.11K |
| 5 |
Bank of New York Mellon
New York
|
-$169 |